Company News
Transasia in Rs 50-crore expansion at its Sikkim manufacturing plant
Transasia Bio-Medicals Ltd. has planned to invest Rs 50 crore in the expansion of its manufacturing facility in Sikkim, which is its fourth largest plant after Mumbai, Daman, and Baddi. Also, the first-ever diagnostics manufacturing facility in Northeast, the expanded facility will significantly enhance Transasia’s capacity to cater to the growing Indian and overseas market demands. Spread over 2 acres, the state-of-the-art facility can produce 6000+ instruments monthly including the complete range of semi-automated analyzers.
Industry Speak
Technological advancements and emerging trends on coagulation testing
Suresh Vazirani
Chairman & Managing Director
Transasia Bio-Medicals Ltd.
“Sikkim is fast becoming a major hub for healthcare manufacturing with 14 major players already there. Transasia’s new facility will further reinforce this besides providing employment to local youth who otherwise would need to move out of the state for such quality opportunities. With this addition of capacity, we are well placed to deliver to the demand arising from continued growth posted by the company both in Indian and overseas markets.”
